Anzeige
Mehr »
Login
Montag, 10.08.2020 Börsentäglich über 12.000 News von 643 internationalen Medien
Spannend! Billiarden-Karten werden auf den Tisch gelegt.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 858560 ISIN: US5324571083 Ticker-Symbol: LLY 
Tradegate
10.08.20
19:35 Uhr
130,06 Euro
+0,32
+0,25 %
Branche
Pharma
Aktienmarkt
S&P 500
S&P 100
1-Jahres-Chart
ELI LILLY AND COMPANY Chart 1 Jahr
5-Tage-Chart
ELI LILLY AND COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
130,22130,3221:34
130,12130,4021:34

Aktuelle News zur ELI LILLY Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18:08Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout15
ELI LILLY Aktie jetzt für 0€ handeln
16:35Eli Lilly teams with Pieris on HER2+ tumors; Opdivo + Yervoy best chemo in mesothelioma1
16:35Innovent and Eli Lilly challenge Merck's mega-blockbuster Keytruda in non-small cell lung cancer field4
13:31Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC1
12:32Pieris Pharmaceuticals, Inc.: Pieris and Lilly Enter Into a Clinical Trial Collaboration to Evaluate Combination of PRS-343 With Ramucirumab and Paclitaxel in Gastric Cancer176BOSTON, MA / ACCESSWIRE / August 10, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...
► Artikel lesen
SaLilly's sintilimab shows treatment benefit in first-line lung cancer3
SaWCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck's Keytruda?11
FrCOVID-19-Forschung: Lilly erprobt monoklonalen Antiköper gegen Corona in Pflegeheimen4
MiNIH to test COVID-19 antibodies in hospitalized patients-starting with Eli Lilly's6
MiLilly: Empagliflozin Reduces Risk Of Cardiovascular Death Or Hospitalization For Heart Failure866INDIANAPOLIS (dpa-AFX) - Boehringer Ingelheim and Eli Lilly and Co. (LLY) said that Empagliflozin met primary endpoint in reducing risk of cardiovascular death or hospitalization for heart...
► Artikel lesen
MiNIH to test Lilly's experimental monoclonal antibody treatment in mild and moderate COVID-19 cases4
MiEli Lilly starts phase 3 trial of antibody treatments against coronavirus in care facilities5
MiEli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study8
DiTrending Market News Tuesday: Facebook, Eli Lilly, Activision12
DiLilly: Maximizing manufacturing capacity is key to COVID-19 antibody strategy1
DiEli Lilly Brings a Coronavirus Drug Study Directly to Senior Care Facilities -- in RVs4
DiEli Lilly begins COVID-19 prevention trial in nursing homes6
DiBetter Coronavirus Stock: Regeneron or Eli Lilly?6
03.08.UPDATE 2-Eli Lilly tests antibody drug to halt COVID-19 spread in U.S. nursing homes4
03.08.Why Eli Lilly's Stock Is Trading Higher Today4
Seite:  Weiter >>
528 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4